Concepedia

Eugenio Morelli

EM

Statistics

Publications

31

Citations

2.3K

H-Index

24

Active since

2012

Affiliations

Dana-Farber Cancer Institute(Current)

Magna Graecia University

VA Boston Healthcare System

University of Milan

Harvard University

Eugenio Morelli is an author at Dana-Farber Cancer Institute specializing in molecular oncology, oncology, and multiple myeloma.

ORCID

Publications per year

2012–2025

31

Publications

31

Drugging the lncRNA MALAT1 via LNA gapmeR ASO inhibits gene expression of proteasome subunits and triggers anti-multiple myeloma activity

Nicola Amodio, Maria Angelica Stamato, Giada Juli et al. · Leukemia · 2018 · 252 citations · Full text

, , +17

Synthetic miR-34a Mimics as a Novel Therapeutic Agent for Multiple Myeloma: <i>In Vitro</i> and <i>In Vivo</i> Evidence

Maria Teresa Di Martino, Emanuela Leone, Nicola Amodio et al. · Clinical Cancer Research · 2012 · 243 citations · Full text

, , +16

Targeting miR-21 Inhibits <i>In Vitro</i> and <i>In Vivo</i> Multiple Myeloma Cell Growth

Emanuela Leone, Eugenio Morelli, Maria Teresa Di Martino et al. · Clinical Cancer Research · 2013 · 217 citations · Full text

, , +16

Bortezomib Induces Anti–Multiple Myeloma Immune Response Mediated by cGAS/STING Pathway Activation

Annamaria Gullà, Eugenio Morelli, Mehmet Samur et al. · Blood Cancer Discovery · 2021 · 137 citations · Full text

, , +17

Selective targeting of IRF4 by synthetic microRNA-125b-5p mimics induces anti-multiple myeloma activity in vitro and in vivo

Eugenio Morelli, Emanuela Leone, Maria Eugenia Gallo Cantafio et al. · Leukemia · 2015 · 126 citations · Full text

, , +17

1–5 of 31